Japan re-paves iPS cell roadmap with eye on clinical destinations
This article was originally published in Scrip
Executive Summary
Hoping to sustain the momentum created by its recent Nobel Prize win for research in the field, Japan has unveiled an updated official roadmap for the development of regenerative medicine technology based on induced pluripotent stem (iPS) cells, which emphasises practical applications and their planned timeframes.